Why specialty infusion costs are straining employer healthcare budgets

Specialty infusion costs are quietly becoming one of the most significant pressures on employer healthcare budgets, according to a recent Benefit News article authored by Rob LaHayne, co-founder of Leap.

In the piece, LaHayne examines how infusion therapies have evolved from a niche clinical service into a major cost driver for self-funded employers. Over the past decade, the U.S. infusion therapy market has more than doubled, growing from approximately $150 billion in 2015 to over $360 billion in 2025, with pharmacy spending increasingly outpacing overall health benefits growth.

At the same time, where and how infusion care is delivered has remained largely unchanged — with significant implications for cost, access, and employee experience.

Key takeaways for employers and benefits leaders

The Benefit News article highlights several dynamics reshaping employer healthcare spend:

• Most infusion care still happens in the highest-cost settings. Roughly 85% of infusions are delivered in hospital outpatient departments or traditional infusion centers, where pricing is often opaque and difficult for employers to manage.
• Provider markups significantly inflate costs. In hospital-based settings, buy-and-bill pricing can drive the cost of the same infusion drug 400% higher, particularly for high-cost specialty therapies.
• The financial stakes are substantial. A single infusion dose for certain conditions can exceed $20,000, meaning pricing inefficiencies and site-of-care decisions compound rapidly across a self-funded population.
• Cost controls often shift the burden to employees. Employers commonly rely on prior authorizations and utilization controls to manage rising spend, which can introduce delays, administrative complexity, and fragmented care for employees managing serious conditions.

A more transparent approach to infusion care

Leap helps self-funded employers reduce specialty infusion costs through transparent pricing and coordinated care.

This post summarizes an article originally published in Employee Benefit News. Read the full article here: https://www.benefitnews.com/opinion/specialty-infusion-drug-costs-are-putting-strain-on-healthcare-spend